SanAntonioPHARMA project by the European Fellowship for pharmacists

The <News> section of the EAHP website (European Association of Hospital Pharmacists) informs the Hospital Pharmacists that in the past two years, the European Fellowship for Pharmacists (EFP) has covered the meetings of the American Society for Clinical Oncology (ASCO) in 2008 and 2009. We are now expanding our project to the 2009 Breast Cancer Symposium in San Antonio as well as the American Society of Clinical Oncology (ASCO), to be held June of 2010.


Please sign up for this FREE educational report through the EFP.

Currently, the website is in French but the pdf will be delivered to you in ENGLISH one month after the symposium. Please follow the directions below to sign up for this educational report.

Go to: www.efp-online.org

* Scroll the right page to the “red flashing” light
* Click on “San Antonio Pharma 2009”
* Enter: Last Name, First Name, Email
* Set your language to “English”


You will receive the report in ENGLISH approximately one month after the meeting.

Feel free to spread this information to your contacts so that as many colleagues may benefit from this unique report of an important medical conference, BY pharmacists, and FOR pharmacists !


Sources

http://www.eahp.eu
http://www.eahp.eu/News/SanAntonioPHARMA-project-by-the-European-Fellowship-for-pharmacists
http://www.efp-online.org/
http://www.asco.org/

New website for health promotion videos launched

The European Commission launches a website for health promotion videos produced in Europe. The aim is to share ideas and best practice and to show what has been done in public health campaigns on issues such as addiction prevention, communicable diseases, cancer or nutrition and physical activity.

You can access the new website from here:
http://www.healthclips.eu/


From the website, you can order a copy of a video to use it for non-commercial information purposes.


Sources

http://ec.europa.eu/health-eu/

http://ec.europa.eu/health-eu/videos/index_en.htm

Information on the benefits of immunization against diseases

Infectious diseases threaten the health of the citizens of the European Union. The responsibility for preventing the transmission of emerging pathogens and the resurgence of others, as well as enhancing the rapid and coordinated response capability to these threats, is therefore shared by national health authorities and the European Institutions.

Vaccination is unquestionably one of the most cost-effective public health measures available to protect citizens against infectious diseases. The wide-spread implementation of vaccination has led to the eradication of smallpox and has made Europe polio-free. All EU Member States have organised immunisation programmes to protect their citizens against serious, sometimes life-threatening diseases. Yet, some vaccines remain undervalued and under-utilised.

Therefore, the EU works together with the Member States to strengthen the advocacy on the benefits of immunisation against diseases where safe and effective vaccines are available. More specifically, the EU supports the Member States in areas such as immunisation of children against priority vaccine preventable diseases (for example measles, mumps, rubella, diphtheria, tetanus, polio, Haemophilus influenzae b, hepatitis B), immunisation against the human papilloma virus and immunisation against seasonal flu.


Links to the EU activities

Public health

• Surveillance of vaccine-preventable infectious diseases
  EUVAC.NET – Surveillance network for vaccine-preventable infectious diseases using epidemiological and laboratory surveillance and managerial methods

• VENICE project
  The Venice project aims to encourage collection and dissemination of knowledge and best practice relating to vaccination and to further develop collaboration and partnership between Member States

• Disease prevention
  Information on the work of the ECDC to reinforce Europe's defences against infectious diseases by pooling European health knowledge and fostering cooperation

• Vaccines against human papilloma virus (HPV)
  In combination with an organised population-wide quality assured cervical cancer screening programme, vaccination against HPV can help to further reduce the incidence and mortality of cervical cancer. Information on cooperation at EU level against cervical cancer.

EC Health Indicators

• Vaccination coverage in children
  Data on the percentage of infants fully vaccinated against against major diseases

European Health Information

• Childhood vaccinations
  Data on childhood vaccinations

Research

• Vaccines for poverty-related diseases
  EU research to develop new drugs and vaccines for HIV, malaria and tubercolosis

• Improving the health of the poor
  EU policy for developing integrated programmes and cooperation to tackle poverty-related diseases

• European and developing countries - clinical trials partnership
  EU initiatives to develop new medical products to fight HIV/AIDS, malaria and tuberculosis in poor countries

Sources

http://ec.europa.eu/health-eu/index_en.htm

http://ec.europa.eu/health-eu/care_for_me/vaccinations/index_en.htm

3rd Master Class in Oncology Pharmacy Practise

The European Society of Oncology Pharmacy (ESOP) and the Panhellenic Society of Hospital Pharmacists are offering the 3rd Master Class in Oncology Pharmacy. The event will be held in the NJV Plaza hotel, in Athens, Greece, on 23-26 November 2009.

The meeting is the next in a line of successful past events, offering fundamental knowledge to pharmacists in the field of oncology, both for their pharmacy preparatory work and for providing adequate care and support to cancer patients.

This year’s Master Class will focus on the following issues:

Monday

• Europe, the Balkans and the future in oncology
• The need for quality standards in oncology pharmacy
• Pharmacist involvement from prescription to administration (Workshop)
• Production procedure & GMP/ Cytotoxic drug deliveries-precautions/ Data management/ Aseptic work/ Documentation/ Delivery of cytotoxic drug preparation/ Validation of procedures and internal inspections
• How to establish and run a cytotoxic preparation service: The experience of different European countries
• Contamination by cytotoxic drugs, adverse effects and associated occupational health risks

Tuesday

• Facilities: rooms, equipment, ventilation, safety cabins. Personal protective equipment: gown, gloves, pumps, etc.
• Devices and safety in use
• Safety Cabinet, isolators, use of devices (Workshop)
• Cytotoxic drug stability
• Demand for ED programmes for preparation and documentation in oncology pharmacy
• Quiz

Wednesday

• Cytotoxic drugs: mechanism of action and their use in clinical pharmacology
• Supportive treatment: pain therapy, nausea-vomiting, fatigue, alopecia, mucositis, diarrhea
(Workshop)
• Clinical protocols
• Pharmacovigilance
• Psychological support for the patient
• How can pharmacists manage their feelings of depression?
• Cancer patient management. From diagnosis to therapy (Imaging, pathology, molecular biology, PET scan, mammography, evaluation of results, therapeutic decisions)
• Patient follow-up
• Cancer prevention in the European Union: strategy and actions

Thursday

• Stability of prepared doses, microbiological risk
• Medication errors
• Emergency in clinical oncology: The medical, pediatric and radiotherapy perspective in oncology and antidotes
• With whom and how do I collaborate in clinical service? (Workshop)
• Quiz

For a detailed timetable of the Master Class, please visit the ESOP website.

Course Details

Official language
The official language of the meeting is English.

Organizer

European Society of Oncology Pharmacy (ESOP)
Panhellenic Society of Hospital Pharmacists (PSHP)
Mindwork Business Solutions
ConEvent GmbH

Number of participants

The maximum number of delegates is 40. Registrations will be handled on a “first come, first served” basis, therefore please make sure you register as early as possible.

Certificate of attendance

Participants will be awarded a certificate of attendance, following appropriate evaluation of
the knowledge acquired during the Course they attend.

Registration

The registration fee is €250 for ESOP members and €300 for non-members. This fee covers your participation in the meeting and social events. Travel and accommodation expenses shall be covered by participants. Registration applications should be directed to Ms. Foteini Papagioti at papagioti.foteini@mind-work.gr , no later than Friday, 20 November 2009, preferably with confirmation of payment of the registration fee. After 20 November, you may only register on-site, at the Secretariat operating in the Master Class venue. If you have preregistered, please make sure you bring your registration confirmation with you, so that you can collect your meeting material.

All payments should be directed to:
MINDWORK BUSINESS SOLUTIONS
Bank Account: 342.00.2320002899
Bank Name: Alpha Bank
IBAN: GR4501403420342002320002899

Attendance

Attendance of all classes and sessions is mandatory for participants. Please note that the
meeting Secretariat will provide you with an electronic badge, which you must scan upon
entering and leaving the classroom.

Travel Arrangements

Please note that all travel arrangements shall be made and covered by participants
themselves. The registration fee does not include travel expenses.

Event Organizer

Mindwork Business Solutions
15, Markou Mpotsari str.
Kifissia, 145 61
Athens, Greece
Tel: +30 210 6231305
Fax: +30 210 6233809
Contact Person: Ms. Foteini Papagioti
papagioti.foteini@mind-work.gr


Source

http://www.esop.li/futureevents.php

A Hospital Pharmacist is elected Co-Chair for Users to IHE-Europe

A hospital pharmacist who played a key role in the creation of the Pharmacy domain for Integrating the Healthcare Enterprise (IHE), Jacqueline Surugue was elected the Co Chair for Users of IHE Europe Steering Committee in June. www.ihe-europe.net

Since 2007, Jacqueline Surugue has served on the Steering Committee of IHE, representing the European Association of Hospital Pharmacists (EAHP).

Completing her term as President of EAHP in June, Jacqueline Surugue takes up her duties as IHE-Europe co-chair, saying, “I will bring my enthusiasm to collaborate with co Chairs and members and my support in establishing IHE Europe as a recognized stakeholder on the European level and a strong partner within IHE international with the aim of a coherent interoperability of health information systems”.

IHE-Europe is represented by an executive board with Co-Chairs and two past Co-Chairs of the European IHE Committee, two representing the vendors, two representing the users of IT systems in health care.

As Co-Chair for Users, Jacqueline Surugue joins Peter Kuenecke, the elected Co-Chair for Vendors, in jointly-directing the activities and operations of the not-for profit organization IHE-Europe aisbl.

Hospitals, health authorities and medical societies participate in the activities of IHE-Europe which is also supported by many sponsoring organisations and companies. The organization was initiated jointly by the European Association of Radiology (EAR) and the European Coordination Committee of the Radiological, Electromedical and Medical IT Industries (COCIR).

Jacqueline Surugue is chief of the Pharmacy Department for the 1,200-bed Centre Hospitalier Georges Renon (Niort) in the Poitou Charentes region of France. She has a broad experience on European level in her role as the president of the European Association of Hospital Pharmacists, a federation of 29 countries from Europe representing 22,000 hospital pharmacists.

She was elected vice president of the Federation Internationale Pharmaceutique (FIP) Hospital Section in 2006 and is an elected member of the National Council of the French Order of Pharmacists.

Integrating the Healthcare Enterprise (IHE) International is an organization that enables users and developers of information technology for healthcare to achieve interoperability of systems through the precise definition of healthcare tasks, the specification of standards-based communication between systems required to support those tasks and the testing of systems to determine that they conform to the specifications. The work is managed by IHE committees and sponsored by various national and international bodies, as described in the IHE Principles of Governance, available at www.ihe.net/governance/.

Sources

http://www.ihe-europe.net/

http://www.ihe-europe.net/content/new_cochair.htm

38th European Symposium on Clinical Pharmacy

In 2009, the European Society of Clinical Pharmacy celebrates its 30th anniversary.

ESCP was indeed founded in Lyon in 1979 by clinical practitioners, researchers and educators from various countries across Europe. After 30 years of continuous development, the value of clinical pharmacy is now recognized and we anticipate a bright future. Within an increasingly complex environment, health professionals must coordinate their actions and learn how to use new technologies to maximize efficiency. Such challenges and pressure on performance should not divert us from our essential purpose: Patient Care.

Scientific Programme

Click here to download the Preliminary Programme

The scientific programme includes keynote lectures, invited lectures, oral free communications, scientific and industry-supported symposia, working group meetings, moderated poster presentations and pre-congress educational courses. The official Symposium language is English. No simultaneous translation will be available.

Tuesday, 3 November 2009
Evening Opening Lecture: Pricing of Drugs & Transparency in Health Care, Richard Laing, WHO

Wednesday, 4 November 2009
Plenary sessions: APPROACHES TO INTERDISCIPLINARY CARE
Plenary 1A: Interdisciplinary Cooperation
Plenary 1B: Interdisciplinary Cooperation in Drug & Therapeutic Committees
Plenary 1C: Interdisciplinary Cooperation in Community Pharmacy

Thursday, 5 November 2009
Plenary session: PATIENT ORIENTED CARE
Plenary 2: Talking to Patients about Pharmacotherapy
Pharmacotherapy update 1: New Developments in Anticoagulant Therapy

Friday, 6 November 2009
Plenary session: TECHNOLOGY AND PATIENT CARE
Plenary 3: Integrating Technology in Patient Care
Pharmacotherapy update 2: Biosimilars

All afternoon parallel sessions are scheduled including interactive workshops, oral communications and poster discussion fora. Masterclasses and workshops will be announced in the Provisional Programme and on this website.

Important Dates and Deadlines
Registration opening: 01 April 2009
Abstract Submission opening: 01 May 2009
Abstract Submission deadline extended to: 20 July 2009, Midnight CET
Early Registration deadline: 31 July 2009
Notifications to Abstract Submitters: 14 Sept 2009
Registration Deadline for Abstract presenters: 29 Sept 2009
Register before 31 July 2009 in order to benefit from the low early-bird rates!


Sources

http://www.escpweb.org/site/cms/
http://www.escp-gsasa2009.org/